Literature DB >> 20187863

Migraine treatment and placebo effect.

José G Speciali1, Mário Peres, Marcelo E Bigal.   

Abstract

Placebos are typically defined as physiologically inactive substances that elicit a therapeutic response. The antipode of the placebo effect is the nocebo effect, or the negative effects of placebo, where unpleasant symptoms (e.g., adverse events) emerge after the administration of placebo. Placebo analgesia is one of the most striking examples of the cognitive modulation of pain perception. Herein we focus on the importance of placebo in headache research. We first review the mechanisms of the placebo effect. We then focus on the importance of placebo in the acute treatment of migraine. We follow by discussing the importance of placebo on the preventive treatment of migraine and our perspectives for the 5 years to come regarding the study of the placebos.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20187863     DOI: 10.1586/ern.10.8

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  11 in total

1.  Percutaneous Tibial Nerve Stimulation vs Sham Stimulation for Fecal Incontinence in Women: NeurOmodulaTion for Accidental Bowel Leakage Randomized Clinical Trial.

Authors:  Halina M Zyczynski; Holly E Richter; Vivian W Sung; Emily S Lukacz; Lily A Arya; David D Rahn; Anthony G Visco; Donna Mazloomdoost; Benjamin Carper; Marie G Gantz
Journal:  Am J Gastroenterol       Date:  2022-04-01       Impact factor: 12.045

2.  A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Tolerability, and Safety of Celecoxib Oral Solution (ELYXYB) in Acute Treatment of Episodic Migraine with or without Aura.

Authors:  Richard B Lipton; Sagar Munjal; Stewart J Tepper; Charlie Iaconangelo; Daniel Serrano
Journal:  J Pain Res       Date:  2021-08-19       Impact factor: 3.133

3.  High-rate repetitive transcranial magnetic stimulation in migraine prophylaxis: a randomized, placebo-controlled study.

Authors:  Usha K Misra; Jayantee Kalita; Sanjeev K Bhoi
Journal:  J Neurol       Date:  2013-08-21       Impact factor: 4.849

4.  Transcutaneous supraorbital neurostimulation in "de novo" patients with migraine without aura: the first Italian experience.

Authors:  Antonio Russo; Alessandro Tessitore; Francesca Conte; Laura Marcuccio; Alfonso Giordano; Gioacchino Tedeschi
Journal:  J Headache Pain       Date:  2015-07-22       Impact factor: 7.277

5.  Long-term Treatment Benefits and Prolonged Efficacy of OnabotulinumtoxinA in Patients Affected by Chronic Migraine and Medication Overuse Headache over 3 Years of Therapy.

Authors:  Simona Guerzoni; Lanfranco Pellesi; Carlo Baraldi; Michela Maria Cainazzo; Andrea Negro; Paolo Martelletti; Luigi Alberto Pini
Journal:  Front Neurol       Date:  2017-11-03       Impact factor: 4.003

6.  Chiropractic spinal manipulative therapy for cervicogenic headache: a single-blinded, placebo, randomized controlled trial.

Authors:  Aleksander Chaibi; Heidi Knackstedt; Peter J Tuchin; Michael Bjørn Russell
Journal:  BMC Res Notes       Date:  2017-07-24

7.  Manual therapy for chronic migraine: a pragmatic randomised controlled trial study protocol.

Authors:  Jim Odell; Carol Clark; Adrian Hunnisett; Osman Hassan Ahmed; Jonathan Branney
Journal:  Chiropr Man Therap       Date:  2019-03-27

8.  Self-reported efficacy of complementary and alternative medicine: the Akershus study of chronic headache.

Authors:  Espen Saxhaug Kristoffersen; Kjersti Aaseth; Ragnhild Berling Grande; Christofer Lundqvist; Michael Bjørn Russell
Journal:  J Headache Pain       Date:  2013-04-18       Impact factor: 7.277

9.  Libertas: a phase II placebo-controlled study of NRL001 in patients with faecal incontinence showed an unexpected and sustained placebo response.

Authors:  L Siproudhis; W Graf; A Emmanuel; D Walker; R Ng Kwet Shing; C Pediconi; J Pilot; S Wexner; J Scholefield
Journal:  Int J Colorectal Dis       Date:  2016-04-13       Impact factor: 2.571

10.  A combination of coenzyme Q10, feverfew and magnesium for migraine prophylaxis: a prospective observational study.

Authors:  Angèle Guilbot; Marie Bangratz; Samira Ait Abdellah; Christian Lucas
Journal:  BMC Complement Altern Med       Date:  2017-08-30       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.